No Nod For Covaxin Yet, Final WHO Assessment On November 3

PUBLISHED ON: October 27, 2021 | Duration: 7 min, 31 sec

  
loading..
The World Health Organisation's technical advisory group on Tuesday sought "additional clarifications" from Bharat Biotech for its COVID-19 vaccine Covaxin to conduct a final "risk-benefit assessment" for Emergency Use Listing of the vaccine. The technical advisory group will now meet on November 3 for a final assessment.
ALSO WATCH
After Omicron Cases Confirmed, "Missing" Passengers A Worry

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com